Skip to main content

Table 4 Agreement between actual prescribing of ICS/LABA for 59 COPD patients (FEV 1 /FVC < 0.7) with no concomitant diagnosis of asthma in 2009/10 and the prescribing recommended based on the 2011 GOLD guidelines

From: Predictors of ICS/LABA prescribing in COPD patients: a study from general practice

  ICS/LABA recommended (FEV1% predicted < 50 or previous exacerbation)  
ICS/LABA Yes No  
prescribed 2009/10    
 Yes 14 9 23
 No 17 19 36
  31a 28 59
  Kappa = 0.13 (SE 0.12)   
  1. aFrequent exacerbation only was recorded in eight patients, predicted FEV1% <50% only in 12 patients, and both findings in 11 patients.